<DOC>
	<DOC>NCT00260377</DOC>
	<brief_summary>Aspirin was proved to be the drug preventing vein grafts from closure and improving clinical outcome after coronary artery bypass surgery. It appears to be effective when being prescribed as early as first 48 hr. after the operation without increasing the incidence of bleeding complications. the exact effective dose is not known.</brief_summary>
	<brief_title>Aspirin Resistance Following Coronary Bypass Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patients undergoing Coronary artery bypass surgery Patients who signed Informed Consent Form Concomitant valve surgery or carotid surgery or offpump surgery Need for anticoagulation therapy for any reason Another antiplatelet medications at least 7 days prior to surgery Contraindication for aspirin treatment Thrombocytopenia / thrombocytopathia NSAIDs treatment for chronic medical conditions Reluctance to participate in the study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Aspirin treatment</keyword>
	<keyword>Aspirin resistance</keyword>
	<keyword>Coronary bypass surgery</keyword>
</DOC>